_id
691854233c536f8df231789b
Ticker
0AAU.LSE
Name
Surgical Science Sweden AB
Exchange
LSE
Address
Drakegatan 7 A, Gothenburg, Sweden, 412 50
Country
UK
Sector
Industry
Currency
SEK
Website
https://www.surgicalscience.com
Description
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a powerful training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was incorporated in 1997 and is based in Gothenburg, Sweden.
Last Close
30.32
Volume
100
Current Price
30.32
Change
-0.357
Last Updated
2026-01-08T13:32:54.582Z
Image
https://logo.clearbit.com/www.surgicalscience.com
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-09-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
5031000
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
-
Short Term Investments
-
Receivables
140353000
Inventories
171247000
Total Current Assets
972380000
Property Plant Equipment
43275000
Total Assets
-
Payables
-
Short Term Debt
-
Long Term Debt
-
Total Liabilities
301636000
Equity
-
Bs_currency_symbol
SEK
Depreciation
16357000
Change In Working Capital
-
Cash From Operations
53121000
Capital Expenditures
3579000
Cash From Investing
-16078000
Cash From Financing
-5077000
Net Change In Cash
31639000
Cf_currency_symbol
SEK
PE
0.1384
PB
-
ROE
-
ROA
-
FCF
49542000
Fcf Percent
-
Piotroski FScore
1
Health Score
46
Deep Value Investing Score
3
Defensive Investing Score
3
Dividend Investing Score
1.5
Economic Moat Investing Score
1.5
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
2.5
Net Net Investing Score
0
Quality Investing Score
0.5
Value Investing Score
3
Quarters > 0 > quarter
2023-09-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
5031000
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
SEK
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
140353000
Quarters > 0 > balance Sheet > inventories
171247000
Quarters > 0 > balance Sheet > total Current Assets
972380000
Quarters > 0 > balance Sheet > property Plant Equipment
43275000
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
-
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
301636000
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
SEK
Quarters > 0 > cash Flow > net Income
47403000
Quarters > 0 > cash Flow > depreciation
16357000
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
53121000
Quarters > 0 > cash Flow > capital Expenditures
3579000
Quarters > 0 > cash Flow > cash From Investing
-16078000
Quarters > 0 > cash Flow > cash From Financing
-5077000
Quarters > 0 > cash Flow > net Change In Cash
31639000
Quarters > 0 > cash Flow > currency_symbol
SEK
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
49542000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
46
Quarters > 1 > quarter
2023-06-30
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
3573000
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
SEK
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
156657000
Quarters > 1 > balance Sheet > inventories
175940000
Quarters > 1 > balance Sheet > total Current Assets
976130000
Quarters > 1 > balance Sheet > property Plant Equipment
45772000
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
-
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
345418000
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
SEK
Quarters > 1 > cash Flow > net Income
38789000
Quarters > 1 > cash Flow > depreciation
11768000
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
85098000
Quarters > 1 > cash Flow > capital Expenditures
2933000
Quarters > 1 > cash Flow > cash From Investing
-9391000
Quarters > 1 > cash Flow > cash From Financing
14759000
Quarters > 1 > cash Flow > net Change In Cash
92342000
Quarters > 1 > cash Flow > currency_symbol
SEK
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
82165000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
46
Quarters > 2 > quarter
2023-03-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
SEK
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
180791000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
-
Quarters > 2 > balance Sheet > property Plant Equipment
46224000
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
-
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
312647000
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
SEK
Quarters > 2 > cash Flow > net Income
49819000
Quarters > 2 > cash Flow > depreciation
11460000
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
85098000
Quarters > 2 > cash Flow > capital Expenditures
2933000
Quarters > 2 > cash Flow > cash From Investing
-6908000
Quarters > 2 > cash Flow > cash From Financing
14759000
Quarters > 2 > cash Flow > net Change In Cash
92342000
Quarters > 2 > cash Flow > currency_symbol
SEK
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
82165000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
46
Quarters > 3 > quarter
2022-12-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
10467000
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
SEK
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
134883000
Quarters > 3 > balance Sheet > total Current Assets
826371000
Quarters > 3 > balance Sheet > property Plant Equipment
51357000
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
305908000
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
SEK
Quarters > 3 > cash Flow > net Income
116520000
Quarters > 3 > cash Flow > depreciation
11460000
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
78549000
Quarters > 3 > cash Flow > capital Expenditures
3715000
Quarters > 3 > cash Flow > cash From Investing
-13465000
Quarters > 3 > cash Flow > cash From Financing
-1288000
Quarters > 3 > cash Flow > net Change In Cash
63627000
Quarters > 3 > cash Flow > currency_symbol
SEK
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
74834000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
46
Annuals > 0 > quarter
2022-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
-
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-
Annuals > 0 > income Statement > net Income
-
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
20199000
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
SEK
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
134883000
Annuals > 0 > balance Sheet > total Current Assets
826371000
Annuals > 0 > balance Sheet > property Plant Equipment
51357000
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
-
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
305908000
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > balance Sheet > currency_symbol
SEK
Annuals > 0 > cash Flow > net Income
187974000
Annuals > 0 > cash Flow > depreciation
-
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
129487000
Annuals > 0 > cash Flow > capital Expenditures
9352000
Annuals > 0 > cash Flow > cash From Investing
-34548000
Annuals > 0 > cash Flow > cash From Financing
17093000
Annuals > 0 > cash Flow > net Change In Cash
117053000
Annuals > 0 > cash Flow > currency_symbol
SEK
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
120135000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
46
Annuals > 1 > quarter
2021-12-31
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
-
Annuals > 1 > income Statement > operating Income
-
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-
Annuals > 1 > income Statement > net Income
-
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
-20444000
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
SEK
Annuals > 1 > balance Sheet > cash
-
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
179789000
Annuals > 1 > balance Sheet > inventories
113107000
Annuals > 1 > balance Sheet > total Current Assets
616909000
Annuals > 1 > balance Sheet > property Plant Equipment
38393000
Annuals > 1 > balance Sheet > total Assets
-
Annuals > 1 > balance Sheet > payables
34368000
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
232377000
Annuals > 1 > balance Sheet > equity
-
Annuals > 1 > balance Sheet > currency_symbol
SEK
Annuals > 1 > cash Flow > net Income
86248000
Annuals > 1 > cash Flow > depreciation
23896000
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
39083000
Annuals > 1 > cash Flow > capital Expenditures
3871000
Annuals > 1 > cash Flow > cash From Investing
-2732614000
Annuals > 1 > cash Flow > cash From Financing
2922463000
Annuals > 1 > cash Flow > net Change In Cash
229523000
Annuals > 1 > cash Flow > currency_symbol
SEK
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-
Annuals > 1 > ratios > ROA
-
Annuals > 1 > ratios > FCF
35212000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
46
Annuals > 2 > quarter
2020-12-31
Annuals > 2 > income Statement > revenue
-
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
-
Annuals > 2 > income Statement > operating Income
-
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-
Annuals > 2 > income Statement > net Income
-
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
4053000
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
SEK
Annuals > 2 > balance Sheet > cash
-
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
32074000
Annuals > 2 > balance Sheet > inventories
12459000
Annuals > 2 > balance Sheet > total Current Assets
133394000
Annuals > 2 > balance Sheet > property Plant Equipment
8548000
Annuals > 2 > balance Sheet > total Assets
-
Annuals > 2 > balance Sheet > payables
2304000
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
31278000
Annuals > 2 > balance Sheet > equity
-
Annuals > 2 > balance Sheet > currency_symbol
SEK
Annuals > 2 > cash Flow > net Income
15606000
Annuals > 2 > cash Flow > depreciation
10250000
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
23225000
Annuals > 2 > cash Flow > capital Expenditures
399000
Annuals > 2 > cash Flow > cash From Investing
-8694000
Annuals > 2 > cash Flow > cash From Financing
4205000
Annuals > 2 > cash Flow > net Change In Cash
17940000
Annuals > 2 > cash Flow > currency_symbol
SEK
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-
Annuals > 2 > ratios > ROA
-
Annuals > 2 > ratios > FCF
22826000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
46
Annuals > 3 > quarter
2019-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
-
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-
Annuals > 3 > income Statement > net Income
-
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
2650000
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
SEK
Annuals > 3 > balance Sheet > cash
-
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
32466000
Annuals > 3 > balance Sheet > inventories
7188000
Annuals > 3 > balance Sheet > total Current Assets
112772000
Annuals > 3 > balance Sheet > property Plant Equipment
9071000
Annuals > 3 > balance Sheet > total Assets
-
Annuals > 3 > balance Sheet > payables
2368000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
39582000
Annuals > 3 > balance Sheet > equity
-
Annuals > 3 > balance Sheet > currency_symbol
SEK
Annuals > 3 > cash Flow > net Income
12598000
Annuals > 3 > cash Flow > depreciation
7228000
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
55202000
Annuals > 3 > cash Flow > capital Expenditures
322000
Annuals > 3 > cash Flow > cash From Investing
-210303000
Annuals > 3 > cash Flow > cash From Financing
185779000
Annuals > 3 > cash Flow > net Change In Cash
30720000
Annuals > 3 > cash Flow > currency_symbol
SEK
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
54880000
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
46
Valuation > metrics > PE
0.1384
Valuation > final Score
70
Valuation > verdict
98.6% Undervalued
Profitability > final Score
50
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > final Score
50
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
50
Prev Liquidities > 1
50
Prev Liquidities > 2
50
Updated At
2026-01-20T22:52:25.045Z
Earnings History > 0 > period
2026-03-31
Earnings History > 0 > report Date
2026-05-12
Earnings History > 0 > date
2026-03-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-12-31
Earnings History > 1 > report Date
2026-02-19
Earnings History > 1 > date
2025-12-31
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-
Earnings History > 1 > eps Estimate
0.92
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-09-30
Earnings History > 2 > report Date
2025-11-13
Earnings History > 2 > date
2025-09-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.3998
Earnings History > 2 > eps Estimate
0.72
Earnings History > 2 > eps Difference
-0.3202
Earnings History > 2 > surprise Percent
-44.4722
Earnings History > 3 > period
2025-06-30
Earnings History > 3 > report Date
2025-08-21
Earnings History > 3 > date
2025-06-30
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.3935
Earnings History > 3 > eps Estimate
0.34
Earnings History > 3 > eps Difference
-0.7335
Earnings History > 3 > surprise Percent
-215.7353
Earnings History > 4 > period
2025-03-31
Earnings History > 4 > report Date
2025-05-14
Earnings History > 4 > date
2025-03-31
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
SEK
Earnings History > 4 > eps Actual
0.6514
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-12-31
Earnings History > 5 > report Date
2025-02-19
Earnings History > 5 > date
2024-12-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
0.7107
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-09-30
Earnings History > 6 > report Date
2024-11-14
Earnings History > 6 > date
2024-09-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
SEK
Earnings History > 6 > eps Actual
0.8432
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-06-30
Earnings History > 7 > report Date
2024-08-22
Earnings History > 7 > date
2024-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
SEK
Earnings History > 7 > eps Actual
0.5599
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2024-03-31
Earnings History > 8 > report Date
2024-05-15
Earnings History > 8 > date
2024-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
SEK
Earnings History > 8 > eps Actual
0.4663
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-12-31
Earnings History > 9 > report Date
2024-03-06
Earnings History > 9 > date
2023-12-31
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
SEK
Earnings History > 9 > eps Actual
1.9198
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-09-30
Earnings History > 10 > report Date
2023-09-30
Earnings History > 10 > date
2023-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
SEK
Earnings History > 10 > eps Actual
0.929
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-06-30
Earnings History > 11 > report Date
2023-06-30
Earnings History > 11 > date
2023-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
SEK
Earnings History > 11 > eps Actual
0.7619
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2023-03-31
Earnings History > 12 > report Date
2023-03-31
Earnings History > 12 > date
2023-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
SEK
Earnings History > 12 > eps Actual
0.9786
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-12-31
Earnings History > 13 > report Date
2022-12-31
Earnings History > 13 > date
2022-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
SEK
Earnings History > 13 > eps Actual
2.2892
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-09-30
Earnings History > 14 > report Date
2022-09-30
Earnings History > 14 > date
2022-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
SEK
Earnings History > 14 > eps Actual
0.5599
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-06-30
Earnings History > 15 > report Date
2022-06-30
Earnings History > 15 > date
2022-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
SEK
Earnings History > 15 > eps Actual
0.52
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2022-03-31
Earnings History > 16 > report Date
2022-03-31
Earnings History > 16 > date
2022-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
SEK
Earnings History > 16 > eps Actual
0.3233
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a state-of-the-art training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a powerful training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was incorporated in 1997 and is based in Gothenburg, Sweden.
Stock Price
SEK0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-09-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
* Institutions hold a combined 0.00% of the total shares of Surgical Science Sweden AB
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
0.92
Date
2025-09-30
EPS Actual
0.3998
EPS Estimate
0.72
EPS Difference
-0.3202
Surprise Percent
-44.4722%
(Last Updated 2023-09-30)
(Last Updated 2023-09-30)
Revenue
SEK 0
Cost Of Revenue
SEK 0
Gross Profit
SEK 0
Operating Expenses
SEK 0
Operating Income
SEK 0
Interest Expense
SEK 0
Pretax Income
SEK 0
Net Income
SEK 0
Income Tax Expense
SEK 0
EBITDA
SEK 0
Total Other Income Expense Net
SEK 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-09-30)
Cash
SEK 0
Short Term Investments
SEK 0
Receivables
SEK 0
Inventories
SEK 0
Total Current Assets
SEK 0
Property Plant Equipment
SEK 0
Total Assets
SEK 0
Payables
SEK 0
Short Term Debt
SEK 0
Long Term Debt
SEK 0
Total Liabilities
SEK 0
Equity
SEK 0
(Last Updated 2023-09-30)
Net Income
SEK 0
Depreciation
SEK 0
Change In Working Capital
SEK 0
Cash From Operations
SEK 0
Capital Expenditures
SEK 0
Cash From Investing
SEK 0
Cash From Financing
SEK 0
Net Change In Cash
SEK 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.